BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 31244689)

  • 1. Baseline Serum Levels of Beclin-1, but Not Inflammatory Factors, May Predict Antidepressant Treatment Response in Chinese Han Patients With MDD: A Preliminary Study.
    He S; Zeng D; Xu F; Zhang J; Zhao N; Wang Q; Shi J; Lin Z; Yu W; Li H
    Front Psychiatry; 2019; 10():378. PubMed ID: 31244689
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Serum brain-derived neurotrophic factor, Val66Met polymorphism and open-label SSRI treatment response in Major Depressive Disorder.
    Smit AJT; Wu GWY; Rampersaud R; Reus VI; Wolkowitz OM; Mellon SH
    Psychoneuroendocrinology; 2024 Jul; 165():107045. PubMed ID: 38636352
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Oxidative stress, inflammation and treatment response in major depression.
    Lindqvist D; Dhabhar FS; James SJ; Hough CM; Jain FA; Bersani FS; Reus VI; Verhoeven JE; Epel ES; Mahan L; Rosser R; Wolkowitz OM; Mellon SH
    Psychoneuroendocrinology; 2017 Feb; 76():197-205. PubMed ID: 27960139
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serum cytokines-based biomarkers in the diagnosis and monitoring of therapeutic response in patients with major depressive disorder.
    Xu Y; Liang J; Sun Y; Zhang Y; Shan F; Ge J; Xia Q
    Int Immunopharmacol; 2023 May; 118():110108. PubMed ID: 37004349
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Biological profiling of prospective antidepressant response in major depressive disorder: Associations with (neuro)inflammation, fatty acid metabolism, and amygdala-reactivity.
    Mocking RJT; Nap TS; Westerink AM; Assies J; Vaz FM; Koeter MWJ; Ruhé HG; Schene AH
    Psychoneuroendocrinology; 2017 May; 79():84-92. PubMed ID: 28262603
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Plasma levels of interleukin-8 and response to paroxetine in patients with major depressive disorder.
    Guan X; Dong ZQ; Hao YN; Shen XL; Xie QL; Chen JM
    Hum Psychopharmacol; 2022 Nov; 37(6):e2855. PubMed ID: 36194639
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Increase in IL-6 levels among major depressive disorder patients after a 6-week treatment with duloxetine 60 mg/day: a preliminary observation.
    Fornaro M; Martino M; Battaglia F; Colicchio S; Perugi G
    Neuropsychiatr Dis Treat; 2011; 7():51-6. PubMed ID: 21430794
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Peripheral cytokine levels and response to antidepressant treatment in depression: a systematic review and meta-analysis.
    Liu JJ; Wei YB; Strawbridge R; Bao Y; Chang S; Shi L; Que J; Gadad BS; Trivedi MH; Kelsoe JR; Lu L
    Mol Psychiatry; 2020 Feb; 25(2):339-350. PubMed ID: 31427752
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pre-treatment allostatic load and metabolic dysregulation predict SSRI response in major depressive disorder: a preliminary report.
    Hough CM; Bersani FS; Mellon SH; Morford AE; Lindqvist D; Reus VI; Epel ES; Wolkowitz OM
    Psychol Med; 2021 Sep; 51(12):2117-2125. PubMed ID: 32438932
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CNS- and ANS-arousal predict response to antidepressant medication: Findings from the randomized iSPOT-D study.
    Olbrich S; Tränkner A; Surova G; Gevirtz R; Gordon E; Hegerl U; Arns M
    J Psychiatr Res; 2016 Feb; 73():108-15. PubMed ID: 26714202
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cortical Thickness Predicts Response Following 2 Weeks of SSRI Regimen in First-Episode, Drug-Naive Major Depressive Disorder: An MRI Study.
    Wu P; Zhang A; Sun N; Lei L; Liu P; Wang Y; Li H; Yang C; Zhang K
    Front Psychiatry; 2021; 12():751756. PubMed ID: 35273524
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sex differences in a double-blind randomized clinical trial with minocycline in treatment-resistant depressed patients: CRP and IL-6 as sex-specific predictors of treatment response.
    Lombardo G; Nettis MA; Hastings C; Zajkowska Z; Mariani N; Nikkheslat N; Worrell C; Enache D; McLaughlin A; Kose M; Bogdanova A; Sforzini L; Cleare AJ; Young AH; Dazzan P; Mondelli V; Pariante CM
    Brain Behav Immun Health; 2022 Dec; 26():100561. PubMed ID: 36467125
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Baseline serum C-reactive protein levels may predict antidepressant treatment responses in patients with major depressive disorder.
    Zhang J; Yue Y; Thapa A; Fang J; Zhao S; Shi W; Yang Z; Li Y; Yuan Y
    J Affect Disord; 2019 May; 250():432-438. PubMed ID: 30878656
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Amygdala Reactivity to Emotional Faces in the Prediction of General and Medication-Specific Responses to Antidepressant Treatment in the Randomized iSPOT-D Trial.
    Williams LM; Korgaonkar MS; Song YC; Paton R; Eagles S; Goldstein-Piekarski A; Grieve SM; Harris AW; Usherwood T; Etkin A
    Neuropsychopharmacology; 2015 Sep; 40(10):2398-408. PubMed ID: 25824424
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fatty acid metabolism and its longitudinal relationship with the hypothalamic-pituitary-adrenal axis in major depression: Associations with prospective antidepressant response.
    Mocking RJ; Verburg HF; Westerink AM; Assies J; Vaz FM; Koeter MW; Ruhé HG; Schene AH
    Psychoneuroendocrinology; 2015 Sep; 59():1-13. PubMed ID: 26010860
    [TBL] [Abstract][Full Text] [Related]  

  • 16. IL-1β, IL-17A, CRP and biologics history might serve as potential markers for clinical response to etanercept in rheumatoid arthritis patients.
    Zhang B; Jiang W
    Inflammopharmacology; 2019 Dec; 27(6):1123-1130. PubMed ID: 31463666
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacologic approaches to treatment resistant depression: Evidences and personal experience.
    Tundo A; de Filippis R; Proietti L
    World J Psychiatry; 2015 Sep; 5(3):330-41. PubMed ID: 26425446
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A Deep Learning Approach for Predicting Antidepressant Response in Major Depression Using Clinical and Genetic Biomarkers.
    Lin E; Kuo PH; Liu YL; Yu YW; Yang AC; Tsai SJ
    Front Psychiatry; 2018; 9():290. PubMed ID: 30034349
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Serotonin and Norepinephrine Reuptake Inhibitors.
    Shelton RC
    Handb Exp Pharmacol; 2019; 250():145-180. PubMed ID: 30838456
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of Antidepressant Treatment on Peripheral Biomarkers in Patients with Major Depressive Disorder (MDD).
    Mosiołek A; Pięta A; Jakima S; Zborowska N; Mosiołek J; Szulc A
    J Clin Med; 2021 Apr; 10(8):. PubMed ID: 33920992
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.